...
首页> 外文期刊>Comparative Medicine >Novel H-shunt Venovenous Bypass for Liver Transplantation in Cynomolgus Macaques
【24h】

Novel H-shunt Venovenous Bypass for Liver Transplantation in Cynomolgus Macaques

机译:Cynomolgus MAAQUES中的新型H分流静脉旁路肝移植

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Cynomolgus monkeys are often used in preclinical transplantation research. Performing liver transplantation in cynomolgus monkeys is challenging because they poorly tolerate portal vein clamping during the anhepatic phase. Finding an alternative to portal vein clamping is necessary before preclinical liver transplant models can be performed with reliable outcomes. We used 3 different techniques to perform 5 liver transplants in male cynomolgus macaques (weight, 7.4-10.8 kg; mismatched for MHC I and II; matched for ABO). In procedure A, we clamped the portal vein briefly, as in human transplants, as well as the superior mesentery artery to minimize congestion at the expense of temporary ischemia (n = 2). In procedure B, we performed a temporary portocaval shunt with extracorporeal venovenous bypass (n = 1). For procedure C, we developed an H-shunt system (modified portocaval shunt) with extracorporeal bypass (n = 2). Postoperative immunosuppression comprised cyclosporine A, mycophenolate mofetil, and steroids. Recipients in procedure A developed hemodynamic instability and were euthanized within 2 d. The recipient that underwent procedure B was euthanized within 11 d due to inferior vena caval thrombosis. The H-shunt in procedure C led to minimal PV congestion during the anhepatic phase, and both recipients reached the 21-d survival endpoint with good graft function. Our novel H-shunt bypass system resulted in successful liver transplantation in cynomolgus macaques, with long-term posttransplant survival possible. This technical innovation makes possible the use of cynomolgus monkeys for preclinical liver transplant tolerance models.
机译:Cynomolgus猴子通常用于临床前移植研究。表演肝脏移植在Cynomolgus猴中是挑战性的,因为它们在肛门腔相期间耐受门静脉夹紧差。在临床前肝移植型号可以用可靠的结果进行之前,需要找到门静脉夹紧的替代方案。我们使用了3种不同的技术在雄性牛仔猴中进行5肝移植(重量,7.4-10.8千克; MHC I和II不匹配;与ABO相匹配)。在术语A中,我们简单地夹紧了门静脉,如人类移植,以及优异的肠系膜动脉,以最小化临时缺血的牺牲(n = 2)的充血。在步骤B中,我们进行了临时的PortCavaVal分流器,具有体外静脉旁路(n = 1)。对于程序C,我们开发了一个H-分流系统(改进的PortCaval分流器),体外旁路(n = 2)。术后免疫抑制包含环孢菌素A,霉酚酸酯,和类固醇。过程中的收件人在2天内开发出血液动力学不稳定,并在2天内被安乐死。由于腔脉血栓形成较差,接受程序B的接受者在11天内被安乐死。过程C中的H分流在肛门粥样阶段期间LED最小的PV充血,并且两个接受者达到了具有良好移植功能的21-D生存终点。我们的新型H-分流旁路系统导致Cynomolgus MAKQUES中成功的肝移植,具有长期的后翻伸生存。这种技术创新使得使用Cynomolgus猴进行临床前肝移植耐受模型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号